Human Gene MIR34A (ENST00000385130.1) from GENCODE V47lift37
  Description: microRNA 34a (from RefSeq NR_029610.1)
Gencode Transcript: ENST00000385130.1
Gencode Gene: ENSG00000207865.1
Transcript (Including UTRs)
   Position: hg19 chr1:9,211,727-9,211,836 Size: 110 Total Exon Count: 1 Strand: -


Page IndexSequence and LinksPrimersCTDRNA-Seq ExpressionOther Species
mRNA DescriptionsOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr1:9,211,727-9,211,836)mRNA (may differ from genome)No protein
Gene SorterGenome BrowserOther Species FASTAGene interactionsTable SchemaBioGPS
EnsemblEntrez GeneExonPrimerHGNCOMIMPubMed
WikipediaBioGrid CRISPR DB

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 0.37 RPKM in Cells - EBV-transformed lymphocytes
Total median expression: 0.48 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
      
      
      
      
      

-  Descriptions from all associated GenBank mRNAs
  EF570048 - Homo sapiens microRNA 34a (MIRN34A) precursor RNA, complete sequence.
EF592573 - Homo sapiens microRNA-34a primary transcript, complete sequence.
EF609116 - Homo sapiens precursor microRNA mir-34a, complete sequence.
CS266366 - Sequence 58 from Patent WO2005118806.
DL076528 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004178 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FU261115 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763617 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FV525818 - Nucleic acid controling mast cell degranulation.
FW421520 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW504782 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER.
HI508133 - Sequence 2 from Patent EP2152722.
HV304516 - JP 2009531018-A/83: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305014 - JP 2009531019-A/83: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW102015 - JP 2013500034-A/142: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW119223 - JP 2013046612-A/83: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW367391 - JP 2012228254-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411784 - JP 2014000079-A/58: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW505133 - JP 2014502606-A/35: MELANOMA TREATMENTS.
HW589552 - JP 2013121348-A/83: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW674130 - JP 2014217381-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067072 - JP 2014012020-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ408233 - JP 2015528002-A/830: CHIRAL CONTROL.
HZ413356 - JP 2014060993-A/83: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ427496 - JP 2014217384-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428299 - JP 2014217385-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429102 - JP 2014217386-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429905 - JP 2014217387-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ501567 - JP 2016025853-A/83: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ769162 - JP 2014223080-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058556 - Sequence 58 from Patent EP2298893.
JA059359 - Sequence 58 from Patent EP2298894.
JA073682 - Sequence 58 from Patent EP2281887.
JA104819 - Sequence 58 from Patent EP2302051.
JA106159 - Sequence 58 from Patent EP2302052.
JA106962 - Sequence 58 from Patent EP2302053.
JA107765 - Sequence 58 from Patent EP2302054.
JA108568 - Sequence 58 from Patent EP2302055.
JA109371 - Sequence 58 from Patent EP2302056.
JA191887 - Sequence 58 from Patent EP2290066.
JA192786 - Sequence 58 from Patent EP2290067.
JA193685 - Sequence 58 from Patent EP2290068.
JA194584 - Sequence 58 from Patent EP2290069.
JA195483 - Sequence 58 from Patent EP2290070.
JA196382 - Sequence 58 from Patent EP2290071.
JA197281 - Sequence 58 from Patent EP2290072.
JA198180 - Sequence 58 from Patent EP2290073.
JA199079 - Sequence 58 from Patent EP2290074.
JA199978 - Sequence 58 from Patent EP2290075.
JA200877 - Sequence 58 from Patent EP2290076.
JA217999 - Sequence 58 from Patent EP2281888.
JA226150 - Sequence 58 from Patent EP2292755.
JA229005 - Sequence 58 from Patent EP2292756.
JA257276 - Sequence 58 from Patent EP2284265.
JA278556 - Sequence 58 from Patent EP2281886.
JA284442 - Sequence 58 from Patent EP2281889.
JA292495 - Sequence 58 from Patent EP2287303.
JA317681 - Sequence 58 from Patent EP2314688.
JA374740 - Sequence 58 from Patent EP2322616.
JA525933 - Sequence 83 from Patent EP2369011.
JA526440 - Sequence 83 from Patent EP2369012.
JA526947 - Sequence 83 from Patent EP2369013.
JA535876 - Sequence 83 from Patent EP2371971.
JA787881 - Sequence 83 from Patent EP2479285.
JA788379 - Sequence 83 from Patent EP2479286.
JA810713 - Sequence 83 from Patent EP2468890.
JA811211 - Sequence 83 from Patent EP2468891.
JA811709 - Sequence 83 from Patent EP2468893.
JA812207 - Sequence 83 from Patent EP2468894.
JA812705 - Sequence 83 from Patent EP2468895.
JA813203 - Sequence 83 from Patent EP2468896.
JA813701 - Sequence 83 from Patent EP2468897.
JA814199 - Sequence 83 from Patent EP2468898.
JA814697 - Sequence 83 from Patent EP2468899.
JA816940 - Sequence 83 from Patent EP2468892.
JA825752 - Sequence 83 from Patent EP2471956.
JA826250 - Sequence 83 from Patent EP2471958.
JB024537 - Sequence 83 from Patent EP2505668.
JB025035 - Sequence 83 from Patent EP2505669.
JB079422 - Sequence 83 from Patent EP2487252.
JB079920 - Sequence 83 from Patent EP2487253.
JB080418 - Sequence 83 from Patent EP2487254.
JB080916 - Sequence 83 from Patent EP2487255.
JB081414 - Sequence 83 from Patent EP2487256.
JB081912 - Sequence 83 from Patent EP2487257.
JB082410 - Sequence 83 from Patent EP2487258.
JB082908 - Sequence 83 from Patent EP2487259.
JB083406 - Sequence 83 from Patent EP2487260.
JB083904 - Sequence 83 from Patent EP2487261.
JB084402 - Sequence 83 from Patent EP2487262.
JB084900 - Sequence 83 from Patent EP2487263.
JB087578 - Sequence 83 from Patent EP2502630.
JB147782 - Sequence 83 from Patent EP2484782.
JB148280 - Sequence 83 from Patent EP2484783.
JB153005 - Sequence 83 from Patent EP2514433.
JB153503 - Sequence 83 from Patent EP2514434.
JB622092 - Sequence 83 from Patent EP2586454.
JB622590 - Sequence 83 from Patent EP2586455.
JC001653 - Sequence 83 from Patent EP2591794.
JC037592 - Sequence 120 from Patent EP2643479.
JC221583 - Sequence 58 from Patent EP2471923.
JC268149 - Sequence 58 from Patent EP2471924.
JC340457 - Sequence 58 from Patent EP2471922.
JC469703 - Sequence 58 from Patent EP2471921.
JC572000 - Sequence 14 from Patent EP2759595.
JC990492 - Sequence 58 from Patent EP2808390.
LF132449 - JP 2016506923-A/14: Composition comprising an encapsulated antagomir.
LF714595 - JP 2016165292-A/58: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856529 - JP 2015142597-A/58: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
LG051567 - KR 1020150036642-A/833: CHIRAL CONTROL.
LG162313 - KR 1020160018451-A/14: Composition comprising an encapsulated antagomir.
LP010721 - Sequence 26 from Patent EP2977463.
LZ228144 - JP 2017524341-A/2: HYBRID TRNA/PRE-MIRNA MOLECULES AND METHODS OF USE.
MS810731 - Sequence 1 from Patent EP3142707.
CS266560 - Sequence 252 from Patent WO2005118806.
DL076722 - METHODS AND COMPOSITIONS INVOLVING MicroRNA.
DM004372 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
FW421714 - METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW367585 - JP 2012228254-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HW411978 - JP 2014000079-A/252: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
HW674324 - JP 2014217381-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ067266 - JP 2014012020-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ427690 - JP 2014217384-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ428493 - JP 2014217385-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ429296 - JP 2014217386-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ430099 - JP 2014217387-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
HZ769356 - JP 2014223080-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
JA058750 - Sequence 252 from Patent EP2298893.
JA059553 - Sequence 252 from Patent EP2298894.
JA073876 - Sequence 252 from Patent EP2281887.
JA105013 - Sequence 252 from Patent EP2302051.
JA106353 - Sequence 252 from Patent EP2302052.
JA107156 - Sequence 252 from Patent EP2302053.
JA107959 - Sequence 252 from Patent EP2302054.
JA108762 - Sequence 252 from Patent EP2302055.
JA109565 - Sequence 252 from Patent EP2302056.
JA192081 - Sequence 252 from Patent EP2290066.
JA192980 - Sequence 252 from Patent EP2290067.
JA193879 - Sequence 252 from Patent EP2290068.
JA194778 - Sequence 252 from Patent EP2290069.
JA195677 - Sequence 252 from Patent EP2290070.
JA196576 - Sequence 252 from Patent EP2290071.
JA197475 - Sequence 252 from Patent EP2290072.
JA198374 - Sequence 252 from Patent EP2290073.
JA199273 - Sequence 252 from Patent EP2290074.
JA200172 - Sequence 252 from Patent EP2290075.
JA201071 - Sequence 252 from Patent EP2290076.
JA218193 - Sequence 252 from Patent EP2281888.
JA226344 - Sequence 252 from Patent EP2292755.
JA229199 - Sequence 252 from Patent EP2292756.
JA257470 - Sequence 252 from Patent EP2284265.
JA278750 - Sequence 252 from Patent EP2281886.
JA284636 - Sequence 252 from Patent EP2281889.
JA292689 - Sequence 252 from Patent EP2287303.
JA317875 - Sequence 252 from Patent EP2314688.
JA374934 - Sequence 252 from Patent EP2322616.
JC221777 - Sequence 252 from Patent EP2471923.
JC268343 - Sequence 252 from Patent EP2471924.
JC340651 - Sequence 252 from Patent EP2471922.
JC469897 - Sequence 252 from Patent EP2471921.
JC990686 - Sequence 252 from Patent EP2808390.
LF714789 - JP 2016165292-A/252: METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES.
LF856723 - JP 2015142597-A/252: METHODS AND COMPOSITIONS INVOLVING MicroRNA.
FW364245 - Oligonucleotides for modulating target RNA activity.
FW504815 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER.
HI508166 - Sequence 35 from Patent EP2152722.
HI560876 - Sequence 91 from Patent EP2190992.
HI965152 - Sequence 437 from Patent WO2010139812.
HI965788 - Sequence 108 from Patent WO2010139811.
HI966654 - Sequence 108 from Patent WO2010139810.
HV593977 - JP 2010538653-A/91: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595154 - JP 2010539959-A/535: Micromirs.
HW101963 - JP 2013500034-A/90: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW505500 - JP 2014502606-A/402: MELANOMA TREATMENTS.
HW913253 - JP 2015504307-A/13: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ074021 - JP 2013535982-A/112: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ083046 - JP 2015513906-A/403: Stem Cell Microparticles.
HZ157711 - JP 2015130862-A/535: Micromirs.
HZ186558 - JP 2015146814-A/307: Oligonucleotides for modulating target RNA activity.
HZ436827 - JP 2015529450-A/403: Stem Cell Microparticles.
HZ466305 - JP 2015531594-A/8: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
HZ480234 - JP 2015535430-A/740: TERMINALLY MODIFIED RNA.
HZ790165 - JP 2016504050-A/1910: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287408 - Sequence 90 from Patent WO2011015720.
JA401190 - Sequence 437 from Patent WO2011080318.
JA402168 - Sequence 437 from Patent WO2011080315.
JA403175 - Sequence 437 from Patent WO2011080316.
JA405806 - Sequence 437 from Patent EP2336353.
JA426978 - Sequence 311 from Patent WO2011072177.
JA429332 - Sequence 437 from Patent WO2011095623.
JA660623 - Sequence 77 from Patent WO2011131354.
JB022201 - Sequence 43 from Patent WO2013026685.
JB022754 - Sequence 8 from Patent WO2013026684.
JB074834 - Sequence 94 from Patent WO2012168448.
JB620062 - Sequence 42 from Patent WO2013063544.
JB620196 - Sequence 176 from Patent WO2013063544.
JB624271 - Sequence 91 from Patent EP2610342.
JB778634 - Sequence 13 from Patent WO2013078283.
JB982240 - Sequence 18 from Patent WO2013190091.
JC172031 - Sequence 403 from Patent WO2013150303.
JC244447 - Sequence 67 from Patent WO2012020308.
JC512897 - Sequence 3150 from Patent WO2014113089.
JC572031 - Sequence 45 from Patent EP2759595.
JC572842 - Sequence 403 from Patent WO2014125276.
JC582530 - Sequence 403 from Patent WO2014125277.
JE954226 - Sequence 403 from Patent WO2015052526.
JE955979 - Sequence 403 from Patent WO2015052527.
JE978632 - Sequence 77 from Patent EP2865765.
LF132480 - JP 2016506923-A/45: Composition comprising an encapsulated antagomir.
LF137731 - JP 2016507550-A/403: Method of Producing Microparticles.
LF160053 - JP 2016513950-A/119: Oligomers with improved off-target profile.
LF162696 - JP 2016513095-A/403: Stem Cell Microparticles and miRNA.
LF953448 - JP 2016534103-A/403: Stem Cell Microparticles and miRNA.
LG005793 - KR 1020150004822-A/403: STEM CELL MICROPARTICLES.
LG053489 - KR 1020150059168-A/403: STEM CELL MICROPARTICLES.
LG162344 - KR 1020160018451-A/45: Composition comprising an encapsulated antagomir.
LG240728 - KR 1020160035087-A/403: STEM CELL MICROPARTICLES AND MIRNA.
LP726414 - Sequence 108 from Patent EP2883966.
LP818684 - Sequence 108 from Patent EP3296406.
LP938626 - Sequence 108 from Patent EP3184651.
LQ070485 - Sequence 809 from Patent EP2964234.
LQ417667 - Sequence 3 from Patent WO2016125163.
LQ441087 - Sequence 94 from Patent EP3029157.
LQ731203 - Sequence 39 from Patent EP3325624.
LV470813 - JP 2016534036-A/403: Stem Cell Microparticles and miRNA.
LY405219 - KR 1020160117535-A/524: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LZ233915 - JP 2017184756-A/307: Oligonucleotides for modulating target RNA activity.
MA260458 - JP 2017505623-A/524: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS673205 - Sequence 8 from Patent EP3135774.
MS833386 - Sequence 91 from Patent EP3112464.
MS834291 - Sequence 437 from Patent EP3112479.
MS901570 - Sequence 43 from Patent EP3156505.
LQ417666 - Sequence 2 from Patent WO2016125163.
AY194151 - Homo sapiens microRNA miR-34, complete sequence.
CQ873674 - Sequence 93 from Patent WO2004076622.
CS548417 - Sequence 1447 from Patent EP1777301.
DD413511 - Regulation of Mammalian Cells.
FV524273 - Nucleic acid controling mast cell degranulation.
FW312159 - DETECTING NUCLEIC ACIDS.
FZ436961 - JP 2011501966-A/8: PROCESS FOR MONITORING COLORECTAL CANCER.
HI463857 - Sequence 2 from Patent EP2124967.
HV335759 - JP 2011093892-A/2: Tumor proliferation suppressor comprising tumor suppressive micro RNA.
HV534432 - WO 2011111715-A/948: Nucleic acid for controlling cell cycle.
JC265631 - Sequence 1 from Patent WO2013017542.
JC334246 - Sequence 164 from Patent EP2487240.
JE869360 - Sequence 1 from Patent WO2015131115.
LF636227 - JP 2016519076-A/1: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF838608 - JP 2016530232-A/3: Biomarkers of miR-34 Activity.
LG134384 - KR 1020150131312-A/1: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LP637005 - Sequence 55 from Patent EP2848702.
LQ069373 - Sequence 1 from Patent WO2015153757.
LY409556 - KR 1020160122850-A/1: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER.
MA264538 - JP 2017507955-A/1: SORAFENIB-MICRORNA COMBINATION THERAPY FOR LIVER CANCER.
AJ550399 - Homo sapiens microRNA mir-34.
CS166329 - Sequence 40 from Patent WO2005078096.
CS265299 - Sequence 41 from Patent EP1627925.
CS444354 - Sequence 41 from Patent WO2006108473.
DI488453 - KR 1020140147919-A/1: Biomaker miR-451 for distinguishing non-alcoholic steatohepatitis.
DI488460 - KR 1020140147920-A/1: Biomaker miR-34a for distinguishing non-alcoholic steatohepatitis.
DI488467 - KR 1020140147921-A/1: Biomaker miR-494-3p for distinguishing non-alcoholic steatohepatitis.
DJ003842 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DJ027121 - Method for predicting or identifying target mRNAs of functional RNAs and use thereof.
DL231871 - Method for the determination of cellular transcriptional regulation.
FU261388 - MICRORNA EXPRESSION ABNORMALITIES IN PANCREATIC ENDOCRINE AND ACINAR TUMORS.
FU763890 - MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
FW362676 - MICRORNA EXPRESSION SIGNATURE FOR PREDICTING SURVIVAL AND METASTASES IN HEPATOCELLULAR CARCINOMA.
FW364244 - Oligonucleotides for modulating target RNA activity.
FW504781 - COMPOSITIONS COMPRISING MIR34 THERAPEUTIC AGENTS FOR TREATING CANCER.
FZ414384 - WO 2011007815-A/274: A method for screening a food which promotes production of milk having immunoregulating effect.
HH981318 - Sequence 78 from Patent EP1723162.
HI377383 - Sequence 10 from Patent EP2087135.
HI508132 - Sequence 1 from Patent EP2152722.
HI528954 - Sequence 34 from Patent EP2142659.
HI539279 - Sequence 103 from Patent EP2160477.
HI560875 - Sequence 90 from Patent EP2190992.
HI929402 - Sequence 9 from Patent EP2258863.
HI965153 - Sequence 438 from Patent WO2010139812.
HI966097 - Sequence 417 from Patent WO2010139811.
HI966963 - Sequence 417 from Patent WO2010139810.
HV304789 - JP 2009531018-A/356: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF LUNG CANCER.
HV305287 - JP 2009531019-A/356: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HV321528 - JP 2011072229-A/35: Diagnosis and therapeutic choice of hypopharyngeal cancer using micro RNA as biomarker.
HV511981 - JP 2011520454-A/96: Methods for Assessing Colorectal Cancer and Compositions for use therein.
HV540977 - WO 2011125469-A/21: A recombinant vaccinia virus regulated by miRNA and use thereof.
HV543935 - JP 2011217617-A/46: Method for testing fibrosis of chronic liver diseases using miRNAs.
HV582960 - JP 2010527616-A/101: Micro-RNA Scaffolds and Non-Naturally Occurring Micro-RNAS.
HV593976 - JP 2010538653-A/90: MIRNA EXPRESSION IN HUMAN PERIPHERAL BLOOD MICROVESICLES AND USES THEREOF.
HV595153 - JP 2010539959-A/534: Micromirs.
HV753278 - JP 2012509865-A/1: Compositions and methods for treating retrovirus infections.
HV753797 - JP 2012509675-A/35: COMPOSITIONS AND METHODS FOR DETECTING SMALL RNAS, AND USES THEREOF.
HV821912 - JP 2011140513-A/274: An Immunostimulating pharmaceutical composition, and a method for producing the immunostimulating pharmaceutical composition.
HV954026 - JP 2012518421-A/938: METHODS OF DETECTING LUNG CANCER.
HV956208 - JP 2012519484-A/5: LIVE ATTENUATED INFLUENZA VIRUS VACCINES COMPRISING MICRORNA RESPONSE ELEMENTS.
HW060376 - JP 2012527478-A/40: Identification of MicroRNAs Involved in Post-Myocardial Infarction Remodeling and Heart Failure.
HW101911 - JP 2013500034-A/38: Use of microRNA for treating diseases associated with a dysfunction of the cilia in multiciliated epithelial cells.
HW119496 - JP 2013046612-A/356: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HW248829 - JP 2013514372-A/28: MICRO-RNA REGULATION IN ISCHEMIA AND ISCHEMIA-REPERFUSION INJURY.
HW505322 - JP 2014502606-A/224: MELANOMA TREATMENTS.
HW589825 - JP 2013121348-A/356: MICRORNA FINGERPRINTS DURING HUMAN MEGAKARYOCYTOPOIESIS.
HW669843 - JP 2013537538-A/574: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
HW913406 - JP 2015504307-A/166: METHODS OF DIAGNOSING AND TREATING IDIOPATHIC PULMONARY FIBROSIS.
HZ074020 - JP 2013535982-A/111: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer.
HZ082744 - JP 2015513906-A/101: Stem Cell Microparticles.
HZ157710 - JP 2015130862-A/534: Micromirs.
HZ186557 - JP 2015146814-A/306: Oligonucleotides for modulating target RNA activity.
HZ376551 - WO 2015133521-A/3: New RNA sequence exhibiting anti-tumor effect.
HZ413629 - JP 2014060993-A/356: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ432168 - JP 2014207909-A/101: Micro-RNA Scaffolds and Non-Naturally Occurring Micro-RNAS.
HZ436525 - JP 2015529450-A/101: Stem Cell Microparticles.
HZ466303 - JP 2015531594-A/6: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
HZ480235 - JP 2015535430-A/741: TERMINALLY MODIFIED RNA.
HZ501840 - JP 2016025853-A/356: MICRORNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF SOLID CANCERS.
HZ790166 - JP 2016504050-A/1911: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
JA287356 - Sequence 38 from Patent WO2011015720.
JA401191 - Sequence 438 from Patent WO2011080318.
JA402169 - Sequence 438 from Patent WO2011080315.
JA403176 - Sequence 438 from Patent WO2011080316.
JA405807 - Sequence 438 from Patent EP2336353.
JA427139 - Sequence 472 from Patent WO2011072177.
JA429333 - Sequence 438 from Patent WO2011095623.
JA483461 - Sequence 96 from Patent EP2283161.
JA526206 - Sequence 356 from Patent EP2369011.
JA526713 - Sequence 356 from Patent EP2369012.
JA527220 - Sequence 356 from Patent EP2369013.
JA536149 - Sequence 356 from Patent EP2371971.
JA660765 - Sequence 219 from Patent WO2011131354.
JA667970 - Sequence 49 from Patent WO2011139911.
JA682630 - Sequence 98 from Patent WO2011149354.
JA715156 - Sequence 938 from Patent EP2401406.
JA729546 - Sequence 5 from Patent EP2403527.
JA781917 - Sequence 28 from Patent EP2513307.
JA788154 - Sequence 356 from Patent EP2479285.
JA788652 - Sequence 356 from Patent EP2479286.
JA792094 - Sequence 143 from Patent WO2012089753.
JA810986 - Sequence 356 from Patent EP2468890.
JA811484 - Sequence 356 from Patent EP2468891.
JA811982 - Sequence 356 from Patent EP2468893.
JA812480 - Sequence 356 from Patent EP2468894.
JA812978 - Sequence 356 from Patent EP2468895.
JA813476 - Sequence 356 from Patent EP2468896.
JA813974 - Sequence 356 from Patent EP2468897.
JA814472 - Sequence 356 from Patent EP2468898.
JA814970 - Sequence 356 from Patent EP2468899.
JA817213 - Sequence 356 from Patent EP2468892.
JA826025 - Sequence 356 from Patent EP2471956.
JA826523 - Sequence 356 from Patent EP2471958.
JB024810 - Sequence 356 from Patent EP2505668.
JB025308 - Sequence 356 from Patent EP2505669.
JB029510 - Sequence 34 from Patent EP2481805.
JB029570 - Sequence 34 from Patent EP2481806.
JB079695 - Sequence 356 from Patent EP2487252.
JB080193 - Sequence 356 from Patent EP2487253.
JB080691 - Sequence 356 from Patent EP2487254.
JB081189 - Sequence 356 from Patent EP2487255.
JB081687 - Sequence 356 from Patent EP2487256.
JB082185 - Sequence 356 from Patent EP2487257.
JB082683 - Sequence 356 from Patent EP2487258.
JB083181 - Sequence 356 from Patent EP2487259.
JB083679 - Sequence 356 from Patent EP2487260.
JB084177 - Sequence 356 from Patent EP2487261.
JB084675 - Sequence 356 from Patent EP2487262.
JB085173 - Sequence 356 from Patent EP2487263.
JB087851 - Sequence 356 from Patent EP2502630.
JB148055 - Sequence 356 from Patent EP2484782.
JB148553 - Sequence 356 from Patent EP2484783.
JB149199 - Sequence 274 from Patent EP2455486.
JB153278 - Sequence 356 from Patent EP2514433.
JB153776 - Sequence 356 from Patent EP2514434.
JB233508 - Sequence 40 from Patent EP2437750.
JB256159 - Sequence 78 from Patent EP2327710.
JB387960 - Sequence 1 from Patent WO2012041959.
JB616197 - Sequence 27 from Patent WO2013107459.
JB620043 - Sequence 23 from Patent WO2013063544.
JB620195 - Sequence 175 from Patent WO2013063544.
JB622365 - Sequence 356 from Patent EP2586454.
JB622863 - Sequence 356 from Patent EP2586455.
JB624150 - Sequence 34 from Patent EP2610347.
JB624270 - Sequence 90 from Patent EP2610342.
JB778787 - Sequence 166 from Patent WO2013078283.
JC001926 - Sequence 356 from Patent EP2591794.
JC032749 - Sequence 21 from Patent WO2013160474.
JC037524 - Sequence 52 from Patent EP2643479.
JC171729 - Sequence 101 from Patent WO2013150303.
JC244446 - Sequence 66 from Patent WO2012020308.
JC244894 - Sequence 522 from Patent WO2012020308.
JC270183 - Sequence 574 from Patent WO2012020307.
JC512898 - Sequence 3151 from Patent WO2014113089.
JC572032 - Sequence 46 from Patent EP2759595.
JC572540 - Sequence 101 from Patent WO2014125276.
JC582228 - Sequence 101 from Patent WO2014125277.
JE867391 - Sequence 198 from Patent WO2015128671.
JE953924 - Sequence 101 from Patent WO2015052526.
JE955677 - Sequence 101 from Patent WO2015052527.
JE978774 - Sequence 219 from Patent EP2865765.
LF132481 - JP 2016506923-A/46: Composition comprising an encapsulated antagomir.
LF137429 - JP 2016507550-A/101: Method of Producing Microparticles.
LF161760 - JP 2016513950-A/1826: Oligomers with improved off-target profile.
LF162394 - JP 2016513095-A/101: Stem Cell Microparticles and miRNA.
LF636310 - JP 2016519076-A/84: COMBINATION CANCER TREATMENTS UTILIZING MICRORNA AND EGFR-TKI INHIBITORS.
LF953146 - JP 2016534103-A/101: Stem Cell Microparticles and miRNA.
LG005491 - KR 1020150004822-A/101: STEM CELL MICROPARTICLES.
LG046505 - KR 1020150023687-A/50: Oligonucleotide-Based Inhibitors Comprising Locked Nucleic Acid Motif.
LG053187 - KR 1020150059168-A/101: STEM CELL MICROPARTICLES.
LG134467 - KR 1020150131312-A/84: COMBINATION CANCER TREATMENTS UTILIZING MICRORNAS AND EGFR-TKI INHIBITORS.
LG162345 - KR 1020160018451-A/46: Composition comprising an encapsulated antagomir.
LG240426 - KR 1020160035087-A/101: STEM CELL MICROPARTICLES AND MIRNA.
LP010710 - Sequence 15 from Patent EP2977463.
LP726723 - Sequence 417 from Patent EP2883966.
LP818993 - Sequence 417 from Patent EP3296406.
LP884025 - Sequence 3 from Patent WO2017167934.
LP884035 - Sequence 13 from Patent WO2017167934.
LP938935 - Sequence 417 from Patent EP3184651.
LP951818 - Sequence 324 from Patent WO2017157650.
LP973065 - Sequence 11 from Patent EP3216869.
LQ070486 - Sequence 810 from Patent EP2964234.
LQ417665 - Sequence 1 from Patent WO2016125163.
LQ754445 - Sequence 23 from Patent EP3329005.
LQ840940 - Sequence 50 from Patent EP3354734.
LV470511 - JP 2016534036-A/101: Stem Cell Microparticles and miRNA.
LV539153 - JP 2016539127-A/154: C/EBP ALPHA COMPOSITIONS AND METHODS OF USE.
LV746125 - JP 2015521626-A/50: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF.
LX154550 - JP 2017509333-A/198: Biomarkers for Endometriosis.
LX270640 - JP 2016056210-A/574: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
LY298555 - KR 1020160079824-A/154: C/EBP ALPHA SHORT ACTIVATING RNA COMPOSITIONS AND METHODS OF USE.
LY405218 - KR 1020160117535-A/523: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
LY416904 - KR 1020160145093-A/10: USE OF MICRO-RIBONUCLEIC ACID(MIRNA) TO DIAGNOSE TRANSPLANT REJECTION AND TOLERANCE OF IMMUNOSUPPRESSION THERAPY.
LY504787 - KR 1020170035932-A/176: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ233914 - JP 2017184756-A/306: Oligonucleotides for modulating target RNA activity.
LZ243068 - JP 2017525350-A/176: MICRORNA BIOMARKER FOR THE DIAGNOSIS OF GASTRIC CANCER.
LZ986415 - JP 2017225396-A/17: Complex and use thereof.
LZ991536 - WO 2017221875-A/17: COMPLEX AND USE THEREOF.
MA260457 - JP 2017505623-A/523: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES.
MS816745 - Sequence 94 from Patent WO2017085287.
MS833385 - Sequence 90 from Patent EP3112464.
MS834292 - Sequence 438 from Patent EP3112479.
MS944920 - Sequence 176 from Patent EP3177739.
MP174434 - Sequence 19 from Patent WO2019058253.
MP129503 - Sequence 403 from Patent EP3470073.
MP162124 - Sequence 101 from Patent WO2019069093.
MP162426 - Sequence 403 from Patent WO2019069093.
MP129201 - Sequence 101 from Patent EP3470073.
MA643986 - JP 2017113010-A/1910: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA731870 - JP 2017140048-A/740: TERMINALLY MODIFIED RNA.
MA643987 - JP 2017113010-A/1911: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA730787 - JP 2017125065-A/574: THERAPEUTIC USES OF MICROVESICLES AND RELATED MICRORNAS.
MA731871 - JP 2017140048-A/741: TERMINALLY MODIFIED RNA.
MA783867 - WO 2018181877-A/8: Anti-cancer agent using miRNA.
MA784178 - WO 2018194089-A/1: GENE-MODIFIED COXSACKIEVIRUS AND PHARMACEUTICAL COMPOSITION.
LQ938809 - Sequence 3 from Patent EP2774990.
LQ938810 - Sequence 4 from Patent EP2774990.
LQ932799 - Sequence 23 from Patent EP2802207.
MA405579 - WO 2018155427-A/353: A probe with reduced false positive binding, a method to desing the probe, and the use thereof.
MA419982 - JP 2018518169-A/33: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420006 - JP 2018518169-A/57: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420023 - JP 2018518169-A/74: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420059 - JP 2018518169-A/110: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420090 - JP 2018518169-A/141: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420107 - JP 2018518169-A/158: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420132 - JP 2018518169-A/183: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420163 - JP 2018518169-A/214: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA420183 - JP 2018518169-A/234: NON-ALCOHOLIC FATTY LIVER DISEASE BIOMARKERS.
MA625402 - JP 2018138044-A/8: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
MA625400 - JP 2018138044-A/6: METHODS OF GENERATING MESENCHYMAL STEM CELLS WHICH SECRETE NEUROTROPHIC FACTORS.
MP065922 - Sequence 36 from Patent WO2018228875.
MP065923 - Sequence 37 from Patent WO2018228875.
MP075720 - Sequence 59 from Patent WO2019002265.
MP070429 - Sequence 26 from Patent WO2018231851.
MP075662 - Sequence 1 from Patent WO2019002265.
MP075676 - Sequence 15 from Patent WO2019002265.
MP075721 - Sequence 60 from Patent WO2019002265.
MA801039 - JP 2018183181-A/1910: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA801040 - JP 2018183181-A/1911: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES.
MA820033 - JP 2018534542-A/3: METHODS FOR DIAGNOSING AND EVALUATING NON-ALCOHOLIC STEATOHEPATITIS.
MA886369 - WO 2019049612-A/9: An antitumor agent, food and beverage for prevention of cancer and an agent for increasing expression of tumor-suppressive microRNA.
MA896107 - JP 2017217007-A/50: OLIGONUCLEOTIDE-BASED INHIBITORS COMPRISING LOCKED NUCLEIC ACID MOTIF.
MP280637 - Sequence 57 from Patent WO2019111197.
MP264454 - Sequence 42 from Patent EP3502269.
MP280638 - Sequence 58 from Patent WO2019111197.
MP283550 - Sequence 57 from Patent WO2019111198.
MP272074 - Sequence 22 from Patent WO2019157381.
MP283551 - Sequence 58 from Patent WO2019111198.
LY628288 - KR 1020180132092-A/3: NON-INVASIVE DIAGNOSTIC OF NON-ALCOHOLIC STEATOHEPATITIS.
LY628298 - KR 1020180132092-A/13: NON-INVASIVE DIAGNOSTIC OF NON-ALCOHOLIC STEATOHEPATITIS.
LY581972 - KR 1020180120565-A/1: Method of providing the information for selecting the drugs for treating EML4-ALK positive non-small-cell lung cancer resistant to ALK inhibitors.
MB119615 - WO 2019117257-A/137: Method of aiding detection of breast cancer.
MB407129 - WO 2019159884-A/619: Kit, device, and method for detection of dementia.
MB407562 - WO 2019159884-A/1052: Kit, device, and method for detection of dementia.
MB406733 - WO 2019159884-A/223: Kit, device, and method for detection of dementia.
MB460604 - JP 2018523492-A/39: METHODS FOR DETECTING AND TREATING LOW-VIRULENCE INFECTIONS.
MB453666 - JP 2018509178-A/232: Methods for Highly Parallel and Accurate Measurement of Nucleic Acids.
MB457995 - JP 2018522558-A/23: MICRORNA BIOMARKERS FOR TRAUMATIC BRAIN INJURY AND METHODS OF USE THEREOF.
MP330039 - Sequence 4 from Patent WO2019180153.
MP335229 - Sequence 11 from Patent WO2019185823.
MP337302 - Sequence 11 from Patent EP3546597.
MP330036 - Sequence 1 from Patent WO2019180153.
MP336917 - Sequence 1 from Patent WO2019185864.

-  Other Names for This Gene
  Alternate Gene Symbols: NR_029610, uc318ssm.1
UCSC ID: ENST00000385130.1
RefSeq Accession: NR_029610.1

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.